Report - Reference ID: 3479730 - Food and Drug Administration palat e (5.7) •Withdrawal of AEDs: Withdrawal of TOPAMAX gradually (5.8) •Hyperammonemia and encephalopathy associated with

Please pass captcha verification before submit form